Research has confirmed that the key targets of Galangin against liver cancer were SRC, ESR1, MMP9, CDK4, CCNB1, MMP2, CDK2, CDK1, CHEK1 and PLK1 (Li et al., 2024). This evidence concerns the gene CCNB1 and liver cancer.